Additionally, it has been suggested that the presence of respiratory allergy may be a protective factor against infection due to reduced expression of the SARS-CoV-2 receptor ACE2 in the nasal and respiratory epithelium [29, 30], and the protection of allergic rhinitis against COVID-19 has been confirmed in an epidemiological study [31]. The gene discussed is ACE2; the disease is COVID-19.